Nefrologia

Kidney replacement therapy as a key performance indicator for population health. A call to action by REDYT, ALCER, EKPF, S.E.N. and RICORS2040-renal

By Alberto Ortiz, Emilio Sánchez, Juan Carlos Julián, Daniel Gallego, Borja Quiroga

Figure 1 from Nefrologia — Figure 1. Ortiz et al.

Study in peoplePopulations

The paper

Alberto Ortiz, Emilio Sánchez, Juan Carlos Julián, Daniel Gallego, Borja Quiroga

RICORS2040-renal; Spanish Registry of Dialysis and Transplantation (REDYT)

Nefrologia, 1 Jan 2026

doi.org/10.1016/j.nefroe.2026.501537 PubMed 42618196

Research Square4 Oct 2026
China faces $6.45 trillion kidney disease burden through 2060
Clinical Journal of the American Society of Nephrology4 Oct 2026
Lower physical performance links to heart failure and death in CKD
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Environmental Pollution9 Oct 2026
Long-term air pollution is linked to chronic kidney disease